{"id":65339,"date":"2026-05-14T20:35:21","date_gmt":"2026-05-14T12:35:21","guid":{"rendered":"https:\/\/flcube.com\/?p=65339"},"modified":"2026-05-14T20:35:22","modified_gmt":"2026-05-14T12:35:22","slug":"basecare-medical-device-secures-nmpa-approval-for-gems-embryo-culture-medium-chinese-ivf-specialist-completes-global-regulatory-triad","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=65339","title":{"rendered":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad"},"content":{"rendered":"\n<p><strong>Basecare Medical Device Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2170:HKG\">HKG: 2170<\/a>), a <strong>high-throughput sequencing-based assisted reproduction specialist<\/strong>, announced it has received <strong>market approval from China&#8217;s National Medical Products Administration (NMPA)<\/strong> for its self-developed <strong>Gems cleavage embryo culture medium<\/strong>. The product now holds complete regulatory clearance across major global markets, having previously secured <strong>CE certification (Europe), FDA clearance (United States), and TGA certification (Australia)<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone-amp-global-market-access\">Regulatory Milestone &amp; Global Market Access<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Regulatory Authority<\/th><th>Status<\/th><th>Geographic Coverage<\/th><\/tr><\/thead><tbody><tr><td><strong>NMPA (China)<\/strong><\/td><td>Approved<\/td><td>Mainland China<\/td><\/tr><tr><td><strong>FDA (USA)<\/strong><\/td><td>Cleared<\/td><td>United States<\/td><\/tr><tr><td><strong>CE Mark (Europe)<\/strong><\/td><td>Certified<\/td><td>European Union<\/td><\/tr><tr><td><strong>TGA (Australia)<\/strong><\/td><td>Certified<\/td><td>Australia<\/td><\/tr><tr><td><strong>Global Reach<\/strong><\/td><td>Complete<\/td><td>All major IVF markets<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-product-profile-amp-clinical-benefits\">Product Profile &amp; Clinical Benefits<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Product:<\/strong> <strong>Gems cleavage embryo culture medium<\/strong><\/li>\n\n\n\n<li><strong>Function:<\/strong> Supports <strong>early embryonic development<\/strong> during in vitro fertilization (IVF) procedures<\/li>\n\n\n\n<li><strong>Key Benefits:<\/strong><\/li>\n\n\n\n<li>Enhances <strong>embryonic stress resistance<\/strong> during critical early development stages<\/li>\n\n\n\n<li>Optimizes culture conditions for improved embryo viability<\/li>\n\n\n\n<li>Addresses specific <strong>clinical needs of assisted reproduction<\/strong><\/li>\n\n\n\n<li><strong>Technology Integration:<\/strong> Complements Basecare&#8217;s high-throughput sequencing expertise in reproductive genomics<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-significance-amp-market-context\">Strategic Significance &amp; Market Context<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-complete-global-regulatory-portfolio\">Complete Global Regulatory Portfolio<\/h3>\n\n\n\n<p>The NMPA approval represents the final piece of Basecare&#8217;s <strong>global regulatory triad<\/strong>, positioning the company as one of the few Chinese medical device manufacturers with comprehensive international market access for assisted reproduction products. This achievement demonstrates:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Excellence:<\/strong> Ability to meet diverse international quality and safety standards<\/li>\n\n\n\n<li><strong>Market Leadership:<\/strong> First-mover advantage in providing globally-certified embryo culture media from China<\/li>\n\n\n\n<li><strong>Commercial Scalability:<\/strong> Unified product platform deployable across all major IVF markets<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-assisted-reproduction-market-dynamics\">Assisted Reproduction Market Dynamics<\/h3>\n\n\n\n<p><strong>Global IVF Market Growth:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Size:<\/strong> Estimated $25+ billion global IVF market with double-digit annual growth<\/li>\n\n\n\n<li><strong>China Opportunity:<\/strong> Rapidly expanding domestic IVF market driven by changing demographics and policy support<\/li>\n\n\n\n<li><strong>Premium Product Demand:<\/strong> Clinics increasingly seek high-quality, internationally-validated culture media<\/li>\n\n\n\n<li><strong>Integration Advantage:<\/strong> Basecare&#8217;s sequencing expertise provides unique value proposition for comprehensive IVF solutions<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-competitive-positioning-amp-commercial-strategy\">Competitive Positioning &amp; Commercial Strategy<\/h2>\n\n\n\n<p><strong>Differentiation Factors:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Chinese Innovation:<\/strong> First domestically-developed embryo culture medium with global regulatory approvals<\/li>\n\n\n\n<li><strong>Quality Parity:<\/strong> Meets same stringent standards as established Western competitors<\/li>\n\n\n\n<li><strong>Cost Competitiveness:<\/strong> Potential pricing advantages while maintaining international quality benchmarks<\/li>\n\n\n\n<li><strong>Integrated Solutions:<\/strong> Combines culture media with Basecare&#8217;s genomic screening capabilities<\/li>\n<\/ul>\n\n\n\n<p><strong>Market Entry Strategy:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Domestic Launch:<\/strong> Leverage NMPA approval to capture growing Chinese IVF market share<\/li>\n\n\n\n<li><strong>International Expansion:<\/strong> Utilize existing regulatory clearances to expand global footprint<\/li>\n\n\n\n<li><strong>Clinic Partnerships:<\/strong> Target high-volume IVF centers seeking comprehensive, quality-assured solutions<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-implications-amp-growth-outlook\">Financial Implications &amp; Growth Outlook<\/h2>\n\n\n\n<p>The NMPA approval unlocks access to China&#8217;s rapidly growing assisted reproduction market, estimated to represent 20-25% of global IVF cycles. Combined with existing international clearances, Gems culture medium positions Basecare for significant revenue growth and margin expansion through premium product sales.<\/p>\n\n\n\n<p>Success in the culture media segment could also serve as a gateway for broader adoption of Basecare&#8217;s integrated IVF-genomics platform, creating cross-selling opportunities and enhancing customer lifetime value.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding market adoption, regulatory compliance, and commercial performance of Gems culture medium. Actual results may differ due to risks including competitive dynamics, market acceptance, regulatory changes, and execution challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2026051301112_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026051301112_c.\"><\/object><a id=\"wp-block-file--media-38668ef8-6625-44f0-b8e4-a5a2f8878d59\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2026051301112_c.pdf\">2026051301112_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/05\/2026051301112_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-38668ef8-6625-44f0-b8e4-a5a2f8878d59\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[1906,1907,15],"class_list":["post-65339","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-basecare-medical","tag-hkg-2170","tag-product-approvals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China&#039;s National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=65339\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad\" \/>\n<meta property=\"og:description\" content=\"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China&#039;s National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=65339\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-14T12:35:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-14T12:35:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad\",\"datePublished\":\"2026-05-14T12:35:21+00:00\",\"dateModified\":\"2026-05-14T12:35:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339\"},\"wordCount\":513,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Basecare Medical\",\"HKG: 2170\",\"Product approvals\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65339#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=65339\",\"name\":\"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-14T12:35:21+00:00\",\"dateModified\":\"2026-05-14T12:35:22+00:00\",\"description\":\"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China's National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65339\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65339#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad - Insight, China&#039;s Pharmaceutical Industry","description":"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China's National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=65339","og_locale":"en_US","og_type":"article","og_title":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad","og_description":"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China's National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).","og_url":"https:\/\/flcube.com\/?p=65339","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-14T12:35:21+00:00","article_modified_time":"2026-05-14T12:35:22+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=65339#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=65339"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad","datePublished":"2026-05-14T12:35:21+00:00","dateModified":"2026-05-14T12:35:22+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=65339"},"wordCount":513,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Basecare Medical","HKG: 2170","Product approvals"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=65339#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=65339","url":"https:\/\/flcube.com\/?p=65339","name":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-14T12:35:21+00:00","dateModified":"2026-05-14T12:35:22+00:00","description":"Basecare Medical Device Co., Ltd. (HKG: 2170), a high-throughput sequencing-based assisted reproduction specialist, announced it has received market approval from China's National Medical Products Administration (NMPA) for its self-developed Gems cleavage embryo culture medium. The product now holds complete regulatory clearance across major global markets, having previously secured CE certification (Europe), FDA clearance (United States), and TGA certification (Australia).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=65339#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=65339"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=65339#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Basecare Medical Device Secures NMPA Approval for Gems Embryo Culture Medium \u2013 Chinese IVF Specialist Completes Global Regulatory Triad"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=65339"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65339\/revisions"}],"predecessor-version":[{"id":65341,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65339\/revisions\/65341"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=65339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=65339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=65339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}